Prosecution Insights
Last updated: April 19, 2026

Axoltis Pharma

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17781214 PEPTIDE COMPOSTIONS AND METHODS FOR TREATING TAUOPATHIES COFFA, SERGIO 1658 Final Rejection May 31, 2022
17767099 Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelination COFFA, SERGIO 1658 Non-Final OA Apr 07, 2022

Managing Axoltis Pharma's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month